Allogeneic hematopoietic cell transplantation in patients with juvenile myelomonocytic leukemia in Korea: a report of the Korean Pediatric Hematology-Oncology Group-Reference-Cited by-同舟云学术

Allogeneic hematopoietic cell transplantation in patients with juvenile myelomonocytic leukemia in Korea: a report of the Korean Pediatric Hematology-Oncology Group

Published:2022-09-27 Issue:1 Volume:58 Page:20-29
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Yi Eun Sang^ORCID,Kim Seong Koo^ORCID,Ju Hee Young^ORCID,Lee Jae Wook^ORCID,Cho Bin^ORCID,Kim Bo Kyung,Kang Hyoung Jin^ORCID,Baek Hee Jo,Kook Hoon,Yang Eu Jeen,Lim Young Tak,Ahn Won Kee^ORCID,Hahn Seung Min,Park Sang Kyu,Yoo Eun Sun,Yoo Keon Hee^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-022-01826-z.pdf

Reference29 articles.

1. Stieglitz E, Mazor T, Olshen AB, Geng H, Gelston LC, Akutagawa J, et al. Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia. Nat Commun. 2017;8:2127.

2. Locatelli F, Algeri M, Merli P, Strocchio L. Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia. Expert Rev Hematol. 2018;11:129–43.

3. Niemeyer CM, Flotho C. Juvenile myelomonocytic leukemia: who’s the driver at the wheel? Blood 2019;133:1060–70.

4. Sanders JE, Buckner CD, Stewart P, Thomas ED. Successful treatment of juvenile chronic granulocytic leukemia with marrow transplantation. Pediatrics 1979;63:44–6.

5. Flotho C, Sommer S, Lübbert M. DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia. Semin Cancer Biol. 2018;51:68–79.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A successful second allogeneic hematopoietic stem cell transplantation from an alternative donor in a patient with loss of HLA heterozygosity relapse of juvenile myelomonocytic leukemia: case series analysis;Pediatric Hematology/Oncology and Immunopathology;2023-09-30

2. Response to chemotherapy in juvenile myelomonocytic leukemia and its clinical implications for survival: A retrospective registry-based study of the Korean Pediatric Hematology-Oncology Group;Leukemia Research;2023-06